
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Operating costs | $3.0M+331.8% | $700K-66.8% | $2.1M-50.2% | $4.2M |
| Loss from operations | -$3.0M-331.8% | -$700K+66.8% | -$2.1M+50.2% | -$4.2M |
| Non-redemption agreement expense | -$223K+50.6% | -$451K+61.0% | -$1.2M | — |
| Trust dividend income | $234K-75.3% | $947K-71.9% | $3.4M-15.4% | $4.0M |
| Change in fair value of warrant liabilities | $14 | — | — | $8.1M |
| Total other income, net | $11K-97.8% | $496K-81.2% | $2.6M-86.2% | $19.0M |
| Net loss | -$3.0M-1373.9% | -$204K-139.1% | $524K-96.5% | $14.8M |
| Redeemable Shares | ||||
| Weighted average shares outstanding (in Shares) | 6.9M+0.0% | 6.9M+3.0% | 6.7M-2.9% | 6.9M |
| Basic net loss per share (in Dollars per share) | -$0.41-1950.0% | -$0.02-150.0% | $0.04-90.7% | $0.43 |
| Diluted net loss per share (in Dollars per share) | -$0.41-1950.0% | -$0.02-150.0% | $0.04-90.7% | $0.43 |
| Non-Redeemable Shares | ||||
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.